Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19

Congqing Wu, Dien Ye, Adam E. Mullick, Zhenyu Li, A. H.Jan Danser, Alan Daugherty, Hong S. Lu

Research output: Contribution to journalLetterpeer-review

28 Scopus citations
Original languageEnglish
Pages (from-to)E29-E30
JournalHypertension
Volume76
Issue number4
DOIs
StatePublished - Oct 1 2020

Bibliographical note

Funding Information:
C. Wu is an National Institutes of Health (NIH)/NHLBI K99 awardee. This work was supported by NIH grants K99HL145117 and R01HL139748.

Funding

C. Wu is an National Institutes of Health (NIH)/NHLBI K99 awardee. This work was supported by NIH grants K99HL145117 and R01HL139748.

FundersFunder number
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)K99HL145117, R01HL139748
National Heart, Lung, and Blood Institute (NHLBI)

    ASJC Scopus subject areas

    • Internal Medicine

    Fingerprint

    Dive into the research topics of 'Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19'. Together they form a unique fingerprint.

    Cite this